Literature DB >> 17116739

A peroxisomal acyltransferase in mouse identifies a novel pathway for taurine conjugation of fatty acids.

Sarah-Jayne Reilly1, Ethna M O'Shea, Ulla Andersson, James O'Byrne, Stefan E H Alexson, Mary C Hunt.   

Abstract

A wide variety of endogenous carboxylic acids and xenobiotics are conjugated with amino acids, before excretion in urine or bile. The conjugation of carboxylic acids and bile acids with taurine and glycine has been widely characterized, and de novo synthesized bile acids are conjugated to either glycine or taurine in peroxisomes. Peroxisomes are also involved in the oxidation of several other lipid molecules, such as very long chain acyl-CoAs, branched chain acyl-CoAs, and prostaglandins. In this study, we have now identified a novel peroxisomal enzyme called acyl-coenzyme A:amino acid N-acyltransferase (ACNAT1). Recombinantly expressed ACNAT1 acts as an acyltransferase that efficiently conjugates very long-chain and long-chain fatty acids to taurine. The enzyme shows no conjugating activity with glycine, showing that it is a specific taurine conjugator. Acnat1 is mainly expressed in liver and kidney, and the gene is localized in a gene cluster, together with two further acyltransferases, one of which conjugates bile acids to glycine and taurine. In conclusion, these data describe ACNAT1 as a new acyltransferase, involved in taurine conjugation of fatty acids in peroxisomes, identifying a novel pathway for production of N-acyltaurines as signaling molecules or for excretion of fatty acids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116739     DOI: 10.1096/fj.06-6919com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

1.  N-acyl taurines are anti-proliferative in prostate cancer cells.

Authors:  Vicky Chatzakos; Katharina Slätis; Tatjana Djureinovic; Thomas Helleday; Mary C Hunt
Journal:  Lipids       Date:  2011-12-11       Impact factor: 1.880

2.  An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase.

Authors:  Jonathan Z Long; Melanie LaCava; Xin Jin; Benjamin F Cravatt
Journal:  J Lipid Res       Date:  2010-11-19       Impact factor: 5.922

Review 3.  Biosynthesis, degradation and pharmacological importance of the fatty acid amides.

Authors:  Emma K Farrell; David J Merkler
Journal:  Drug Discov Today       Date:  2008-04-03       Impact factor: 7.851

4.  Endogenous N-acyl taurines regulate skin wound healing.

Authors:  Oscar Sasso; Silvia Pontis; Andrea Armirotti; Giorgia Cardinali; Daniela Kovacs; Marco Migliore; Maria Summa; Guillermo Moreno-Sanz; Mauro Picardo; Daniele Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-13       Impact factor: 11.205

5.  N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis.

Authors:  Trisha J Grevengoed; Samuel A J Trammell; Michele K McKinney; Natalia Petersen; Rebecca L Cardone; Jens S Svenningsen; Daisuke Ogasawara; Christina C Nexøe-Larsen; Filip K Knop; Thue W Schwartz; Richard G Kibbey; Benjamin F Cravatt; Matthew P Gillum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-18       Impact factor: 11.205

Review 6.  Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.

Authors:  Paul P Van Veldhoven
Journal:  J Lipid Res       Date:  2010-06-17       Impact factor: 5.922

7.  A Roadmap to the Structure-Related Metabolism Pathways of Per- and Polyfluoroalkyl Substances in the Early Life Stages of Zebrafish (Danio rerio).

Authors:  Jiajun Han; Wen Gu; Holly Barrett; Diwen Yang; Song Tang; Jianxian Sun; Jiabao Liu; Henry M Krause; Keith A Houck; Hui Peng
Journal:  Environ Health Perspect       Date:  2021-07-21       Impact factor: 9.031

8.  Evolutionary Analysis of Bile Acid-Conjugating Enzymes Reveals a Complex Duplication and Reciprocal Loss History.

Authors:  Bogdan M Kirilenko; Lee R Hagey; Stephen Barnes; Charles N Falany; Michael Hiller
Journal:  Genome Biol Evol       Date:  2019-11-01       Impact factor: 3.416

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.